24 March – Pre-day forums (Life Science Companies only), FIL (Feira Internacional de Lisboa), | 25-26 March - Main days, Lisbon Congress Centre, Portugal
Empowering early- to growth-stage life science
Access to Capital: Connect with global investors
Strategic Partnerships: Build growth-driving relationships
Expert Knowledge: Gain transformative insights
“Where global leaders in life sciences drive innovation, investment, & impactful collaborations.”
- Venture Development Manager, Biotech, NLC Health Ventures
Co-located with Bio-Europe Spring for Spring Innovation Week
Save 50% off your Bio-Europe Spring Ticket when booking your partnering pass to LSX Europe
What is LSX World Congress Europe?
LSX World Congress Europe (LSX Europe) is a leading life science fundraising and investment event, bringing innovators and investors together through strategic 1:1 meetings and targeted networking.
Early- to mid-stage biotechnology, medical devices, diagnostics, and digital health companies, including university spin-outs, are attending seeking investment and collaboration opportunities.
Active life science investors attend, looking for new investments and syndication.
Through our proven partnering format, conversations turn into real partnerships and successful raises.
Connect with Purpose in Lisbon
Where Biotech, Medtech & Pharmatech converge
Bringing founders, investors, pharma and innovators together across three tracks - in one event.
Spot crossover opportunities and partnerships you won’t find in siloed events
Compare strategies, talent and tech trends shaping the next wave of growth
More investor touchpoints - convergence attracts capital across sectors and stages
Spring Innovation Week in Lisbon
For the first time, BIO-Europe Spring (23–25 March) and LSX World Congress Europe (25–26 March) take place back-to-back in Lisbon.
One Trip to Lisbon. Double the Impact.
- Extend your network across two major events
- Maximise ROI with four days in one city
- Meet leaders across stages - seed to commercial
How to take part
Choose the pass that matches your goals - learn, meet, showcase or invest.
Content Pass - access the programme, insights and onsite networking
Partnering Pass - unlock 1:1 meetings and targeted introductions
Showcase Pass - present your company and maximise visibility
Investor Pass - connect with deal flow and syndication opportunities
Focused Content: Case Studies, New Data, and the Expertise of Industry-Leading Speakers
Early Innovation & Technology Translation - Next-gen science, platforms, and the path from lab to launch.
Capital Markets & Investment Strategies - Funding trends across VC, public markets, and M&A.
Market Opportunities & Commercialisation - Where value is built: AI, partnering, pricing, and growth markets.
Digital Transformation & AI Integration - How pharma is applying digital and AI across strategy, workflows and LLM-enabled innovation.
Clinical Innovation & Patient Care - Using digital tools and AI to improve trials, personalise care and boost patient outcomes and adherence.
Investment & Partnership Strategies - Funding and collaboration models shaping pharmatech - from VC/CVC to pharma–startup–health system partnerships.
Investment & Partnership - Market dynamics for medtech growth - funding realities, strategic partnerships, and how to position for acquisitions and successful exits.
Innovation & Market Access - How medtech reaches and scales in-market - global expansion, reimbursement, and key growth areas from women’s health to wearables and remote monitoring.
Meet our 2026 speakers...
The numbers that matter
1,500+
Senior Attendees
500+
Investors
250+
Expert Speakers
4000+
1:1 Partnering Meetings
150+
Partnering Booths
3
Conferences
Ways to Attend
Attend as a delegate
- Hear from medtech, biotech and pharmatech industry leaders
- Connect through one-to-one partnering
- Access case studies and discuss strategy
Present your company
- Increase your visibility
- Showcase your innovations
- Attract new investors
Join as an investor
- Access new investment opportunities
- Find new opportunities for syndication
- Understand the latest developments
Medtronic
A unique opportunity for companies, big and small.
Partnership Opportunities
The event offers numerous sponsorship opportunities to showcase your brand and offerings, demonstrate your thought leadership expertise and engage with leaders across the life science ecosystem.
To find out more contact us directly:
How can LSX Europe help you?
Intelligence
Acting as an active conduit of industry insights, innovation, trends, best practices & benchmarking
Investment
Leveraging our extensive network we help match life science innovators with the right investors
Community
Organising formal and informal opportunities to foster connections through networking and serendipitous meetings
FAQs
What is LSX World Congress Europe?
LSX World Congress is Europe’s premier life sciences event that brings together senior decision makers across biotech, medtech, pharma, investors, and R&D/BD teams. Together, they share insights, forge strategic partnerships, secure financing, and drive innovation.
Where and when is LSX World Congress Europe being held?
LSX World Congress Europe (or LSX Europe) takes place 25-26 March 2026 at the Lisbon Congress Centre, Lisbon, Portugal.
What companies are speaking at LSX World Congress Europe (LSX Europe)?
Our speaking programme features speakers from a diverse mix of biopharmaceutical, pharmaceutical, medtech, healthtech, and corporate venture capital firms. Including:
Jazz Pharmaceuticals
Baxter
Elekta
M Ventures
Novo Holdings
High‑Tech Gründerfonds (HTGF)
Gilde Healthcare
Forbion
Untethered Ventures
Solventum
WeHealth / Servier
Who should attend LSX Europe?
The event is designed for a cross‑section of the life sciences ecosystem: C‑suite executives, founders/CEOs, investors (VCs, crossover, corporate), BD&L and licensing leads, R&D and innovation heads, technology providers, and service companies.
What is the format and what to expect?
A Pre-Day on Tuesday 24 March focuses on CEO and Partnering Forums as closed-door roundtable discussions - View Pre-Day Agenda here.
The main event is held over two days (Wednesday 25 - Thursday 26 March 2026) with the following:
- Thought leadership and expert speakers in biotech, medtech, and pharmatech including: 90-minute expert insight sessions with interactive Q&A, panel discussions with industry leaders, and real-world case studies and practical frameworks
- Qualified 1:1 partnering as a core feature to facilitate deal conversations
- Networking breaks, exhibitor booths or innovation showcases
- Opportunities to present your company, pitch to investors, or sponsor the event
As an investor attending LSX Europe, what should I focus on?
- Identify high-potential biotech, medtech and pharmatech innovators seeking funding.
- Use the 1:1 partnering platform to connect with start-ups that fit your portfolio.
- Attend investment-focused sessions to spot new trends and co-investment opportunities (knowing where capital is flowing, and which areas are under the radar)
- Attend early innovation & translation sessions (to spot de risked or platform opportunities).
- Network with fellow investors, corporates and BD leaders to expand your deal pipeline.
- Focus on companies with strong science and clear commercial pathways.
How do I qualify for an Investor Pass?
Please check our terms and conditions on the Investor Qualification page below:
How can I make the most at LSX Europe as a start-up CEO?
Here’s some tips:
- Prepare a short “elevator pitch” summarising your platform, indication, value creation plan.
- Research the investors and pharma companies who will be attending and prioritise networking with them.
- Attend sessions relevant to your growth stage and market focus.
- Use partnering app to pre-book 1:1 meetings early to secure time with investors and partners.
- Be visible – Ask questions in panels that show you are thinking about commercial strategy/market access, engage in networking breaks and showcase opportunities.
- Follow up quickly to turn new connections into lasting relationships.